Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “BIPOLAR I DISORDER”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)UnknownNCT00422331
What this trial is testing

Safety and Efficacy Study of Lithium in Bipolar Disorder

Who this might be right for
Bipolar DisorderMania
JDS Pharmaceuticals 206
Large-scale testing (Phase 3)Ended earlyNCT01467713
What this trial is testing

Efficacy and Safety of Ramelteon Sublingual as Adjunctive Therapy for Maintenance Treatment of Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Takeda 642
Large-scale testing (Phase 3)Ended earlyNCT03768726
What this trial is testing

Extension Study Evaluating The Safety And Tolerability Of Flexible Doses Of Oral Ziprasidone In Children And Adolescents With Bipolar I Disorder

Who this might be right for
Bipolar Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 23
Large-scale testing (Phase 3)Study completedNCT00606320
What this trial is testing

A Multicenter, Investigative Study of the Safety and Efficacy of Extended Administration of Aripiprazole in Combination With Mood Stabilizer for the Treatment of Patients With Bipolar Disorder Experiencing a Manic or Mixed Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Co., Ltd. 59
Large-scale testing (Phase 3)Study completedNCT06462586
What this trial is testing

Study of Lumateperone in the Acute Treatment of Patients With Bipolar Mania

Who this might be right for
Bipolar Disorder, Manic
Intra-Cellular Therapies, Inc. 354
Not applicableLooking for participantsNCT07622927
What this trial is testing

FOCUS Bipolar: Families Opening Conversations for Understanding Signs

Who this might be right for
Bipolar Disorder (BD)Bipolar Disorder I or IIBipolar Disorder Family Members+1 more
University of Texas Southwestern Medical Center 200
Large-scale testing (Phase 3)Ended earlyNCT01131559
What this trial is testing

Adjunctive Lisdexamfetamine (LDX) in Bipolar Depression

Who this might be right for
BipolarDepression
Lindner Center of HOPE 50
Large-scale testing (Phase 3)Study completedNCT00257166
What this trial is testing

Safety and Efficacy of Ziprasidone in Children and Adolescents With Bipolar I Disorder (Manic or Mixed)

Who this might be right for
Bipolar Disorder
Pfizer's Upjohn has merged with Mylan to form Viatris Inc. 238
Not applicableTemporarily pausedNCT05340686
What this trial is testing

Braining- Aerobic Physical Activity as Add on Treatment in Bipolar Depression

Who this might be right for
Bipolar DisorderBipolar DepressionBipolar I Disorder+3 more
Region Stockholm 54
Post-approval studies (Phase 4)Study completedNCT00485771
What this trial is testing

Olanzapine/Fluoxetine Combination Versus Comparator in the Treatment of Bipolar I Depression

Who this might be right for
Bipolar Disorder
Eli Lilly and Company 403
Post-approval studies (Phase 4)Study completedNCT00182013
What this trial is testing

Open-Label Comparative Study of Risperidone Versus Olanzapine Versus Quetiapine for Mania in Children and Adolescents With Bipolar I and Bipolar II Disorder

Who this might be right for
Bipolar Spectrum Disorder
Massachusetts General Hospital 106
Large-scale testing (Phase 3)Study completedNCT00132678
What this trial is testing

The Safety and Efficacy of Injectable Risperidone in the Prevention of Bipolar Mood Episodes

Who this might be right for
Bipolar Disorder
Johnson & Johnson Pharmaceutical Research & Development, L.L.C. 559
Testing effectiveness (Phase 2)Looking for participantsNCT07185815
What this trial is testing

Pharmacokinetics, Safety, Tolerability and Efficacy of a Subcutaneous Long-Acting Injection of Cariprazine (Cariprazine Depot) in Subjects Eligible for Treatment With Oral Cariprazine

Who this might be right for
SchizophreniaBipolar I DisorderMajor Depressive Disorder
Mapi Pharma Ltd. 24
Large-scale testing (Phase 3)Study completedNCT00721955
What this trial is testing

Staccato Loxapine in Agitated Patients With Bipolar Disorder

Who this might be right for
Bipolar I Disorder
Alexza Pharmaceuticals, Inc. 314
Not applicableLooking for participantsNCT07211750
What this trial is testing

Integrated Care for Older Adults With Major Depression and Physical Multimorbidity - The I-CONNECT

Who this might be right for
MultimorbidityOlder Adults (65 Years and Older)Mood Disorders+3 more
KU Leuven 82
Not applicableStudy completedNCT01998516
What this trial is testing

Emotional Intelligence in Schizophrenia and Bipolar-I- Disorder

Who this might be right for
SchizophreniaBipolar I Disorder
Medical University Innsbruck 350
Testing effectiveness (Phase 2)Looking for participantsNCT05837104
What this trial is testing

Efficacy and Safety of Magnesium Vitamin B6 in First Episode Bipolar Disorder

Who this might be right for
Bipolar I DisorderDepression, AnxietyStress
Mclean Hospital 40
Not applicableStudy completedNCT05870501
What this trial is testing

Synaptic Imaging and Network Activity in Treatment Resistant Depression

Who this might be right for
Depressive DisorderDepressive Disorder, MajorDepressive Disorder, Treatment-Resistant+5 more
King's College London 56
Large-scale testing (Phase 3)Study completedNCT00094432
What this trial is testing

Aripiprazole in Patients With Bipolar I Disorder With a Major Depressive Episode

Who this might be right for
Bipolar I Disorder
Otsuka Pharmaceutical Development & Commercialization, Inc. 650
Testing effectiveness (Phase 2)Looking for participantsNCT06696755
What this trial is testing

Assess Adverse Events and Change in Disease Activity of Oral Icalcaprant in Adult Participants With Bipolar I or II Disorder

Who this might be right for
Bipolar I DisorderBipolar II Disorder
AbbVie 195
Next Page